Alpha Wave Global’s Amylyx Pharmaceuticals AMLX Stock Holding History

Alpha Wave Global’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.98M	Sell	142,336 -175,342	-55%	-$2.47M	0.25%	15
2025 Q4	$3.84M	Sell	317,678 -9,634	-3%	-$131K	0.47%	14
2025 Q3	$4.45M	Buy	327,312 +51,470	+19%	+$484K	0.45%	18
2025 Q2	$1.77M	Buy	275,842 +88,531	+47%	+$431K	0.19%	27
2025 Q1	$663K	Buy	187,311 +38,684	+26%	+$138K	0.3%	19
2024 Q4	$562K	Sell	148,627 -520,860	-78%	-$2.45M	0.26%	19
2024 Q3	$2.17M	Buy	+669,487	New	+$1.5M	0.67%	15
2024 Q1	–	Sell	-846,240	Closed	-$12.5M	–	28
2023 Q4	$12.5M	Sell	846,240 -7,022	-0.8%	-$108K	6.01%	6
2023 Q3	$15.6M	Hold	853,262	–	–	9.88%	4
2023 Q2	$18.4M	Sell	853,262 -77,075	-8%	-$2.08M	12.06%	2
2023 Q1	$27.3M	Buy	930,337 +109,117	+13%	+$3.79M	10.08%	2
2022 Q4	$30.3M	Buy	821,220 +120,585	+17%	+$4.28M	5.54%	5
2022 Q3	$19.7M	Hold	700,635	–	–	2.33%	9
2022 Q2	$13.5M	Buy	700,635 +83,415	+14%	+$990K	1.39%	17
2022 Q1	$7.93M	Buy	+617,220	New	+$13.9M	0.71%	35

Other funds holding AMLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Alpha Wave Global's AMLX Position: Q1 2026 in Review

Alpha Wave Global reduced its Amylyx Pharmaceuticals (AMLX) stake by 55% in Q1 2026, selling an estimated $2.47M and leaving 142,336 shares worth $1.98M. The position accounts for 0.25% of the portfolio, ranked #15.

Alpha Wave Global first reported a position in AMLX in Q1 2022 and has held it in 15 quarters since. The position peaked at $30.3M in Q4 2022. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

Alpha Wave Global held 142,336 shares of Amylyx Pharmaceuticals worth $1.98M as of Q1 2026.
Alpha Wave Global sold 175,342 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $2.47M.
Amylyx Pharmaceuticals made up 0.25% of Alpha Wave Global's portfolio in Q1 2026, its #15 holding.
Alpha Wave Global first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 15 quarters since.
Alpha Wave Global's Amylyx Pharmaceuticals position peaked at $30.3M in Q4 2022.
171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Alpha Wave Global's 13F filing for Q1 2026, filed 14 May 2026.